As of 2024-12-15, the Relative Valuation of Hemogenyx Pharmaceuticals PLC (HEMO.L) is - GBP. This relative valuation is based on P/E multiples. With the latest stock price at 420.00 GBP, the upside of Hemogenyx Pharmaceuticals PLC based on Relative Valuation is -.
The range of the Relative Valuation is - GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-29 | -3.12 |
| 2024-11-28 | -3.25 |
| 2024-11-27 | -2.96 |
| 2024-11-26 | -2.84 |
| 2024-11-25 | -2.58 |
| 2024-11-22 | -3.32 |
| 2024-11-21 | -4.22 |
| 2024-11-20 | -3.97 |
| 2024-11-19 | -4.22 |
| 2024-11-18 | -3.77 |
| 2024-11-15 | -3.32 |
| 2024-11-14 | -2.91 |
| 2024-11-13 | -3.22 |
| 2024-11-12 | -3.07 |
| 2024-11-11 | -3.21 |
| 2024-11-08 | -3.50 |
| 2024-11-07 | -3.58 |
| 2024-11-06 | -3.59 |
| 2024-11-05 | -3.74 |
| 2024-11-04 | -3.67 |
| 2024-11-01 | -3.67 |
| 2024-10-31 | -3.72 |
| 2024-10-30 | -3.85 |
| 2024-10-29 | -3.67 |
| 2024-10-28 | -3.74 |
| 2024-10-25 | -4.13 |
| 2024-10-24 | -3.63 |
| 2024-10-23 | -3.30 |
| 2024-10-22 | -3.67 |
| 2024-10-21 | -3.83 |
| 2024-10-18 | -3.91 |
| 2024-10-17 | -3.09 |
| 2024-10-16 | -3.12 |
| 2024-10-15 | -3.23 |
| 2024-10-14 | -3.21 |
| 2024-10-11 | -3.60 |
| 2024-10-10 | -3.64 |
| 2024-10-09 | -3.60 |
| 2024-10-08 | -3.58 |
| 2024-10-07 | -3.64 |
| 2024-10-04 | -4.10 |
| 2024-10-03 | -4.11 |
| 2024-10-02 | -4.36 |
| 2024-10-01 | -4.44 |
| 2024-09-30 | -4.47 |
| 2024-09-27 | -4.48 |
| 2024-09-26 | -4.89 |
| 2024-09-25 | -4.62 |
| 2024-09-24 | -4.33 |
| 2024-09-23 | -4.12 |